The grant will support the consortium's ongoing efforts to clinically validate data analysis software for monitoring treatment responses to cancer vaccines.
Researchers find that a personalized ovarian cancer vaccine appears safe, the Los Angeles Times reports.
Synthetic Genomics is working on speeding up flu vaccine production, according to the San Diego Union-Tribune.
Early trial of experimental gene-based Zika vaccine indicates it is tolerated and leads to an antibody response.
The Universal Influenza Vaccine Initiative, led by Vanderbilt and the Human Vaccines Project, has turned to omics and AI to create more effective flu vaccines.
In PNAS this week: grape genomes give insight into domestication, columnar cacti classification, and more.
The sequencing of a more than 100-year-old smallpox vaccine finds that it contains horsepox, researchers write in NEJM.
Neon Therapeutics is sponsoring a Phase Ib trial of neoantigen-based vaccines in combination with anti-PD-1 treatment in melanoma, lung cancer, and bladder cancer.
The two companies plan to combine their respective gene editing and neoantigen discover technologies in order to develop new T cell therapies for cancer patients.
Two independent research teams published findings for melanoma patients treated with vaccines developed against neo-antigens in their tumors that sequencing uncovered.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.